One-hour MRSA test receives FDA clearance

Sunnyvale, CA molecular diagnostics company, Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for Xpert(R) MRSA NxG, the next generation methicillin-resistant Staphylococcus aureus (MRSA) infection control test from the leader in healthcare-associated infection (HAI) testing. Xpert(R) MRSA NxG is an accurate, on-demand, molecular test that delivers actionable results ["]

The post One-hour MRSA test receives FDA clearance appeared first on Outbreak News Today.